Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.5 GBX | 0.00% | 0.00% | -8.81% |
04-02 | Roadside shares suspended; Adnams looks for funds | AN |
03-26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Sales 2023 | 43.78M 54.69M 0 | Sales 2024 * | 38.3M 47.84M 0 | Capitalization | 46.27M 57.8M 0 |
---|---|---|---|---|---|
Net income 2023 | -2M -2.5M - | Net income 2024 * | - 0 - | EV / Sales 2023 | 1.15 x |
Net Debt 2023 * | 7.2M 8.99M 0 | Net cash position 2024 * | 9.3M 11.62M 0 | EV / Sales 2024 * | 0.97 x |
P/E ratio 2023 |
-20.9
x | P/E ratio 2024 * |
259
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 64.53% |
Current month | -4.17% | ||
1 month | -4.17% | ||
3 months | -10.78% | ||
6 months | -9.21% | ||
Current year | -8.81% |
Managers | Title | Age | Since |
---|---|---|---|
Tom Crawford
CHM | Chairman | 56 | 25/10/20 |
Eric Dodd
DFI | Director of Finance/CFO | 54 | - |
Julia Mueller
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 25/07/22 | |
Eric Dodd
DFI | Director of Finance/CFO | 54 | - |
Director/Board Member | 55 | 16/02/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 103.5 | 0.00% | 600 |
25/04/24 | 103.5 | 0.00% | 0 |
24/04/24 | 103.5 | 0.00% | 0 |
23/04/24 | 103.5 | 0.00% | 4,953 |
22/04/24 | 103.5 | 0.00% | 0 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.81% | 57.63M | |
+11.17% | 322B | |
+24.75% | 216B | |
+2.41% | 149B | |
+10.65% | 56.27B | |
+8.71% | 32.13B | |
-4.57% | 27.45B | |
+103.03% | 22.62B | |
+20.22% | 19.55B | |
+0.04% | 14.61B |
- Stock Market
- Equities
- KBT Stock